AHRQ RFA-HS-10-003

Recovery Act 2009 Limited Competition: AHRQ Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE) Grants (R01)

Application Due Date(s):  December 16, 2009

This AHRQ Funding Opportunity Announcement (FOA), supported by funds provided to AHRQ under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, invites Research Project Grant (R01) applications for large projects in comparative effectiveness aimed at generating new knowledge to help inform decision making in priority areas of clinical care. The impact of these studies should have a high likelihood of creating major advancements in clinical care.

Applications may be up to three years in duration with a budget supported by AHRQ not to exceed $10 million in total costs over the three year period. The annual costs awarded to a grant under this FOA may vary by year, but the maximum costs in any one year may not exceed $4 million total costs and the budget for the entire project period cannot exceed $10 million total costs.  Applications that exceed three years in length, $4 million total costs in any one year, or $10 million in total costs over the project period will not be reviewed.   Funding beyond the first year will be contingent upon a review and acceptance by Agency staff of the annual progress report.

The Research Plan component may not exceed 25 pages, including tables, graphs, figures, diagrams, and charts.

RFA:  http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-10-003.html